Does RISANKIZUMAB-RZAA Cause Skin hyperpigmentation? 11 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Skin hyperpigmentation have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
11
Reports of Skin hyperpigmentation with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
0
Deaths
3
Hospitalizations
How Dangerous Is Skin hyperpigmentation From RISANKIZUMAB-RZAA?
Of the 11 reports, 3 (27.3%) required hospitalization, and 1 (9.1%) were considered life-threatening.
Is Skin hyperpigmentation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Skin hyperpigmentation?
ADAPALENE (2,811)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (2,277)
BIMATOPROST (189)
AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE (182)
DUPILUMAB (177)
MINOCYCLINE (144)
LENALIDOMIDE (142)
METHOTREXATE (142)
CAPECITABINE (136)
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES (120)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Skin hyperpigmentation Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA